227 related articles for article (PubMed ID: 25576916)
1. Functional repair of p53 mutation in colorectal cancer cells using trans-splicing.
He X; Liao J; Liu F; Yan J; Yan J; Shang H; Dou Q; Chang Y; Lin J; Song Y
Oncotarget; 2015 Feb; 6(4):2034-45. PubMed ID: 25576916
[TBL] [Abstract][Full Text] [Related]
2. Trans-splicing repair of mutant p53 suppresses the growth of hepatocellular carcinoma cells in vitro and in vivo.
He X; Liu F; Yan J; Zhang Y; Yan J; Shang H; Dou Q; Zhao Q; Song Y
Sci Rep; 2015 Mar; 5():8705. PubMed ID: 25732051
[TBL] [Abstract][Full Text] [Related]
3. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
[TBL] [Abstract][Full Text] [Related]
4. CP-31398 prevents the growth of p53-mutated colorectal cancer cells in vitro and in vivo.
He X; Kong X; Yan J; Yan J; Zhang Y; Wu Q; Chang Y; Shang H; Dou Q; Song Y; Liu F
Tumour Biol; 2015 Mar; 36(3):1437-44. PubMed ID: 25663456
[TBL] [Abstract][Full Text] [Related]
5. Murine double minute 2 siRNA and wild-type p53 gene therapy interact positively with zinc on prostate tumours in vitro and in vivo.
Gu J; Wang B; Liu Y; Zhong L; Tang Y; Guo H; Jiang T; Wang L; Li Y; Cai L
Eur J Cancer; 2014 Apr; 50(6):1184-94. PubMed ID: 24447832
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus expressing RIZ1 in tumor suppressor gene therapy of microsatellite-unstable colorectal cancers.
Jiang GL; Huang S
Cancer Res; 2001 Mar; 61(5):1796-8. PubMed ID: 11280725
[TBL] [Abstract][Full Text] [Related]
7. Ribozyme-mediated induction of apoptosis in human cancer cells by targeted repair of mutant p53 RNA.
Shin KS; Sullenger BA; Lee SW
Mol Ther; 2004 Aug; 10(2):365-72. PubMed ID: 15294183
[TBL] [Abstract][Full Text] [Related]
8. Anticancer activity of oncolytic adenoviruses carrying p53 is augmented by 11R in gallbladder cancer cell lines in vitro and in vivo.
Wang J; Yu Y; Yan Z; Hu Z; Li L; Li J; Jiang X; Qian Q
Oncol Rep; 2013 Aug; 30(2):833-41. PubMed ID: 23727990
[TBL] [Abstract][Full Text] [Related]
9. Cancer-type organic anion transporting polypeptide 1B3 is a target for cancer suicide gene therapy using RNA trans-splicing technology.
Sun Y; Piñón Hofbauer J; Harada M; Wöss K; Koller U; Morio H; Stierschneider A; Kitamura K; Hashimoto M; Chiba K; Akita H; Anzai N; Reichelt J; Bauer JW; Guttmann-Gruber C; Furihata T
Cancer Lett; 2018 Oct; 433():107-116. PubMed ID: 29960051
[TBL] [Abstract][Full Text] [Related]
10. Cepharanthine exhibits a potent anticancer activity in p53-mutated colorectal cancer cells through upregulation of p21Waf1/Cip1.
Rattanawong A; Payon V; Limpanasittikul W; Boonkrai C; Mutirangura A; Wonganan P
Oncol Rep; 2018 Jan; 39(1):227-238. PubMed ID: 29138869
[TBL] [Abstract][Full Text] [Related]
11. In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer.
Spitz FR; Nguyen D; Skibber JM; Cusack J; Roth JA; Cristiano RJ
Anticancer Res; 1996; 16(6B):3415-22. PubMed ID: 9042200
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effect of intratumoral administration of bone marrow-derived dendritic cells transduced with wild-type p53 gene.
Murakami T; Tokunaga N; Waku T; Gomi S; Kagawa S; Tanaka N; Fujiwara T
Clin Cancer Res; 2004 Jun; 10(11):3871-80. PubMed ID: 15173096
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated p53 treatment enhances photodynamic antitumor response.
Lim DS; Bae SM; Kwak SY; Park EK; Kim JK; Han SJ; Oh CH; Lee CH; Lee WY; Ahn WS
Hum Gene Ther; 2006 Mar; 17(3):347-52. PubMed ID: 16544983
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of p53-targeted gene expression and visualization of p53 transcriptional activity following intratumoral administration of adenoviral p53 in vivo.
Ohtani S; Kagawa S; Tango Y; Umeoka T; Tokunaga N; Tsunemitsu Y; Roth JA; Taya Y; Tanaka N; Fujiwara T
Mol Cancer Ther; 2004 Jan; 3(1):93-100. PubMed ID: 14749479
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein.
Harris MP; Sutjipto S; Wills KN; Hancock W; Cornell D; Johnson DE; Gregory RJ; Shepard HM; Maneval DC
Cancer Gene Ther; 1996; 3(2):121-30. PubMed ID: 8729911
[TBL] [Abstract][Full Text] [Related]
16. Effects of electrogenetherapy with p53wt combined with cisplatin on curvival of human tumor cell lines with different p53 status.
Cemazar M; Grosel A; Glavac D; Kotnik V; Skobrne M; Kranjc S; Mir LM; Andre F; Opolon P; Sersa G
DNA Cell Biol; 2003 Dec; 22(12):765-75. PubMed ID: 14683587
[TBL] [Abstract][Full Text] [Related]
17. NOB1 is essential for the survival of RKO colorectal cancer cells.
He XW; Feng T; Yin QL; Jian YW; Liu T
World J Gastroenterol; 2015 Jan; 21(3):868-77. PubMed ID: 25624720
[TBL] [Abstract][Full Text] [Related]
18. In vivo reprogramming of hTERT by trans-splicing ribozyme to target tumor cells.
Hong SH; Jeong JS; Lee YJ; Jung HI; Cho KS; Kim CM; Kwon BS; Sullenger BA; Lee SW; Kim IH
Mol Ther; 2008 Jan; 16(1):74-80. PubMed ID: 17700543
[TBL] [Abstract][Full Text] [Related]
19. Antitumor bioactivity of adenovirus-mediated p27mt in colorectal cancer cell line SW480.
Sun ZQ; Deng CS; Xu SY; Du Y
World J Gastroenterol; 2008 Oct; 14(38):5827-33. PubMed ID: 18855981
[TBL] [Abstract][Full Text] [Related]
20. CP-31398 inhibits the growth of p53-mutated liver cancer cells in vitro and in vivo.
He XX; Zhang YN; Yan JW; Yan JJ; Wu Q; Song YH
Tumour Biol; 2016 Jan; 37(1):807-15. PubMed ID: 26250460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]